Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's After-Market Session

Author: Benzinga Insights | June 24, 2025 05:06pm

Gainers

  • Citius Pharmaceuticals (NASDAQ:CTXR) shares increased by 13.6% to $1.46 during Tuesday's after-market session. The company's market cap stands at $11.1 million.
  • Cibus (NASDAQ:CBUS) stock rose 11.54% to $1.74. The company's market cap stands at $73.0 million.
  • LakeShore Biopharma (NASDAQ:LSB) shares rose 9.11% to $1.04. The company's market cap stands at $18.5 million.
  • NeuroOne Medical Tech (NASDAQ:NMTC) shares rose 6.62% to $0.74. The company's market cap stands at $32.9 million.
  • Ontrak (NASDAQ:OTRK) shares rose 6.62% to $1.12. The market value of their outstanding shares is at $5.6 million.
  • Nektar Therapeutics (NASDAQ:NKTR) stock increased by 6.29% to $26.0. The company's market cap stands at $118.3 million.

Losers

  • XTL Biopharmaceuticals (NASDAQ:XTLB) shares declined by 11.5% to $1.16 during Tuesday's after-market session. The market value of their outstanding shares is at $8.9 million.
  • OneMedNet (NASDAQ:ONMD) shares fell 10.35% to $0.61. The company's market cap stands at $10.3 million.
  • Forte Biosciences (NASDAQ:FBRX) shares declined by 10.31% to $12.71. The market value of their outstanding shares is at $84.0 million.
  • InspireMD (NASDAQ:NSPR) stock declined by 8.55% to $2.25. The market value of their outstanding shares is at $77.2 million.
  • CASI Pharmaceuticals (NASDAQ:CASI) shares declined by 8.09% to $1.25. The market value of their outstanding shares is at $19.0 million.
  • Lixte Biotechnology (NASDAQ:LIXT) shares decreased by 7.95% to $0.8. The market value of their outstanding shares is at $2.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: CASI CBUS CTXR FBRX LIXT LSB NKTR NMTC NSPR ONMD OTRK XTLB

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist